EW card
EW price forecast
Edwards Lifesciences$107,11
P/E now is 60,5. Average over 5 years: 33,7 (range 29–44). The stock is 79% above its history.
Base · FY2030
$182,01+13,7% a year
The base case gives 13,7% a year, above your target of 10%.
Settings
%
No analyst consensus: assumptions come from the company's last 5 years. Change any in the table.
Calculated from your assumptions. Not an investment recommendation.
Base · FY2030$182,01+13,7% a year